Katrina Sleeman - Concepedia

Author

Katrina Sleeman

Centers for Disease Control and Prevention ORCID

Also Known As

K. Sleeman, K.W. SLEEMAN, Katrina Sleeman

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Battelle Columbia University ICAP Global Health

About

Katrina Sleeman is an author at Centers for Disease Control and Prevention specializing in medicine, virology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.6K
2	Public Health	3	3	225
3	Health Sciences	1	1	11
4	Natural Sciences	1	1	524
5	Biochemistry	1	1	524

Katrina Sleeman

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication Kiira Ratia, Scott D. Pegan, Jun Takayama, Proceedings of the National Academy of Sciences Viral ReplicationMolecular BiologyAntiviral DrugViral Structural ProteinChemical Biology	2008	524
<i>In Vitro</i>Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses Katrina Sleeman, Vasiliy P. Mishin, Varough Deyde, Antimicrobial Agents and Chemotherapy VaccinationMedicineImmunologyDrug-resistant InfluenzaAntiviral Drug Development	2010	141
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors Arun K. Ghosh, Gangli Gong, Valerie Grum‐Tokars, Bioorganic & Medicinal Chemistry Letters MedicineImmunologyAntiviral ResponseAntiviral Drug DevelopmentVirology	2008	135
Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011 Stephen Lindstrom, Rebecca Garten, Amanda Balish, Emerging infectious diseases Pdm09 VirusVirus EpidemiologyImmunologyFlu VaccinationUnited States	2012	135
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease Arun K. Ghosh, Jun Takayama, Yoann Aubin, Journal of Medicinal Chemistry	2009	134
Progress with Scale-Up of HIV Viral Load Monitoring — Seven Sub-Saharan African Countries, January 2015–June 2016 Shirley Lee Lecher, Jason Williams, Peter N. Fonjungo, MMWR Morbidity and Mortality Weekly Report World Health OrganizationVirus EpidemiologyViral DynamicViral Load MonitoringCovid-19	2016	117
Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance Xufang Deng, Sarah E. St. John, Heather L. Osswald, Journal of Virology	2014	102
Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility <i>in vitro</i> Larisa V. Gubareva, A. Angelica Trujillo, Margaret Okomo‐Adhiambo, Antiviral Therapy	2010	94
Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses Margaret Okomo‐Adhiambo, Ha Nguyen, Katrina Sleeman, Antiviral Research Viral EvolutionHost Cell SelectionImmunologyAntiviral Drug DevelopmentVirology	2009	90
Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective Margaret Okomo‐Adhiambo, Katrina Sleeman, Kristina Ballenger, Viruses Virus EpidemiologyViral DiagnosticsAntiviral DrugNeuraminidase InhibitorsInfluenza Vaccines	2010	83

Page 1